Francisco Brito-Aleman
Rheumatology · Corpus Christi, TXNPI 1073076964
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 91.6% of the total across 168 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 22.5% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,651, more than ten times the $250 reported in 2023. That places this record below the midpoint for rheumatology clinicians in TX, where the typical reported total is $3,779.
Across 168 payments — averaging $26.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$1K
- AbbVie$737
- AstraZeneca$685
- Johnson & Johnson$675
- Aurinia Pharma U.S., Inc.$197
- Pfizer$148
- plus $1K from 16 others
What the payments were for
- Consulting fees$1754%
- Food & beverage$4,08392%
- Education$1994%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 40 | $1,004 |
| AbbVie | 28 | $737 |
| AstraZeneca(2 entities) | 23 | $685 |
| Johnson & Johnson | 18 | $675 |
| Aurinia Pharma U.S., Inc. | 9 | $197 |
| Pfizer | 7 | $148 |
| ANI Pharmaceuticals, Inc. | 7 | $144 |
| UCB, Inc. | 6 | $122 |
| E.r. Squibb & Sons, L.L.C. | 6 | $122 |
| Janssen Scientific Affairs, LLC | 1 | $118 |
| Novartis | 5 | $116 |
| GSK | 3 | $62 |
| Genentech USA, Inc. | 3 | $59 |
| Exact Sciences | 2 | $55 |
| Sandoz | 2 | $45 |
| Radius Health, Inc. | 2 | $40 |
| Nevro Corp. | 1 | $29 |
| Lilly USA, LLC | 1 | $25 |
| Invivyd Inc | 1 | $23 |
| Octapharma USA, Inc. | 1 | $20 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
| Henry Schein, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,457 in reported general payments places this provider in the 50th percentile of 512 rheumatology providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 26 | $254,645 |
| Enbrel SureclickEtanercept | 29 | $250,531 |
| Orencia ClickjectAbatacept | 35 | $208,363 |
| Xeljanz XrTofacitinib Citrate | 26 | $146,001 |
| MethotrexateMethotrexate Sodium | 55 | $445 |
| Hydroxychloroquine Sulfate | 13 | $344 |
| Leflunomide | 13 | $149 |
| Gabapentin | 18 | $135 |
| Prednisone | 27 | $99 |
| Alendronate Sodium | 13 | $48 |
| Folic Acid | 17 | $36 |
| Famotidine | 13 | $11 |
Paid to pharmacies, not to this prescriber.
Other rheumatology in Corpus Christi
- John CushDallas$3.7M
- Sanjay ChabraEl Paso$3.3M
- Dhiman BasuColleyville$1.8M
- Frank WellborneNew Braunfels$1.4M
- Christopher ParkerWest Lake Hills$1.4M
- Pendleton WickershamSan Antonio$954K
- Henry TownsendPlano$738K
- Zoran KurepaDallas$483K
- Giovanni GeslaniDallas$415K
- Dianne PetroneDallas$401K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.